Thomas A. DePasquale (Tom De) is a 1982 graduate of the University of Virginia McIntire School of Commerce where he earned a degree in Commerce with a concentration in Accounting. He and his husband, Rafik, live in metro DC with their two children Lena and Luke.
In 2012, Mr. DePasquale was a founder of Cerium Pharmaceuticals, where he also serves as the chairman and executive vice president. The drug company will bring its first product to market in 2023.
In 1999, Mr. DePasquale founded Outtask, Inc., a travel booking technology company. As president and CEO, he grew Outtask’s market cap to over $200M in just six years and in 2002, he was the recipient of Ernst & Young’s prestigious Entrepreneur of the Year award. In 2006, Outtask merged with Concur Technologies to form the fundamental technology for end-to-end travel booking and expense management. After the merger, he served as Concur’s executive vice president of technology, guiding the company’s technology strategy and development until 2011.
Before founding Outtask, Mr. DePasquale held several senior positions with companies in Northern Virginia. After college, he began his career at Arthur Andersen, LLP, and at age 25, he founded Reltech, a technology company that was acquired by Platinum Technology. After the acquisition, he became part of Platinum’s five-member executive team and helped grow the company’s annual revenue to over $1B.
Mr. DePasquale is a lifelong resident of the Commonwealth of Virginia. The son of two high school educators, he developed an appreciation for the value of education at an early age. He attended Virginia public schools from elementary school through college, which gave him the educational foundation needed to become a visionary technology executive, entrepreneur, and philanthropist. He has spent over 30 years founding, funding, and guiding technology businesses that serve unmet needs in the marketplace. Each company was based in Virginia and employed some of Northern Virginia’s best technical talent.
Over the years, Mr. DePasquale has supported a variety of charitable causes, but has focused his support on healthcare and education. Most recently, he made a substantial pledge to the INOVA Health Foundation. He has been a long-time supporter of the Cystic Fibrosis Foundation and the Multiple Sclerosis Foundation. Additionally, he has supported higher education and the University of Virginia community through the UVA Fund.
Mr. DePasquale was appointed to the Board of Visitors by Governor McAuliffe in 2016 and reappointed by Governor Northam in 2020.